New legislation proposed by a bipartisan and bicameral group of Congressional legislators and supported by the North Carolina ...

Cincinnati's 1819 Venture Lab Demo Day showcases local health care innovations, highlighting the city's growing role in the ...

Unexpected delays, infighting and a staffing crisis are fueling investors’ unease.

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

Just 10 years ago, there was virtually no biopharmaceutical industry in China. But now, almost all global big pharma ...

Biotechnology today demands not just domain knowledge but also creativity, ethics, and transdisciplinary thinking, as ...

The FDA has named Tracy Beth Høeg, M.D., Ph.D., as acting director of its Center for Drug Evaluation and Research, continuing ...

Join Bisnow’s Chicago Quantum & Life Science Forum - the only event bringing together researchers, entrepreneurs, investors ...

In the Large-Cap Pharmaceuticals industry, Lilly, J&J and Sanofi are worth retaining as the industry shows some recovery.

Angelini’s investments will be made through its Angelini Ventures arm. EIB and Angelini plan to support between seven and 10 ...

As biotech firms shed jobs and life sciences funding dries up, policymakers have started to see defense technology as a way ...

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...